A comprehensive view of Respiratory / Lung Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
GSK champions global health equity, workplace excellence; company focuses on healthcare access in Kenya, earns top employer status in Belgium
Published:
September 18, 2024
by Industry Intelligence Inc.
|
GSK reports positive data on co-administration of AREXVY and SHINGRIX vaccines; trial meets primary endpoint with non-inferior immune response and acceptable safety profiles for both vaccines
Published:
September 18, 2024
by GSK Group (GlaxoSmithKline)
|
FDA approves Merck's KEYTRUDA with chemotherapy for advanced mesothelioma; treatment shows 21% reduction in death risk versus chemotherapy alone in Phase 3 trial
Published:
September 18, 2024
by Merck & Co. Inc.
|
AstraZeneca's Fasenra approved in US for eosinophilic granulomatosis with polyangiitis; MANDARA trial shows 60% of patients achieved remission, 41% stopped oral corticosteroids
Published:
September 18, 2024
by AstraZeneca AB
|
Nasal spray flu vaccine, based on UW-Madison tech, shows promise alongside high-dose shot; trial participants had increased protective antibodies, immune responses compared to shot alone
Published:
September 17, 2024
by Contify Life Science News
|
Ask us about our Tissue & Hygiene market view